Ratings coverage on Celldex Therapeutics Inc (NASDAQ: CLDX), Immunomedics Incorporated (NASDAQ: IMMU), YPF Sociedad Anonima (NYSE: YPF), CVR Partners (NYSE: UAN) and Cintas (NASDAQ: CTAS) was initiated by analysts this week.
Oppenheimer initiated coverage on Celldex Therapeutics Inc (CLDX). They placed an “outperform” rating and a price target of $6.00 on the company.
Oppenheimer initiated coverage on shares of Immunomedics Incorporated (IMMU). They placed an “outperform” rating and a price target of $6.00 on the company.
Raymond James (NYSE:RJF) initiated coverage on YPF Sociedad Anonima (YPF). They placed an “outperform” rating on the company.
Goldman Sachs (NYSE:GS) initiated coverage on shares of CVR Partners (UAN). They placed a “neutral” rating on the company.
Stifel Nicolaus initiated coverage on Cintas (CTAS). They placed a “hold” rating and a price target of $30.70 on the company.
No comments:
Post a Comment